Terms‡ | Estimate Percentage | Estimate | p value | ||
---|---|---|---|---|---|
Demographics | |||||
Interaction of Sex and Race | |||||
Black Female | Reference | Reference | |||
Black Male | 10.0% | 0.095 (0.074, 0.117) | < 0.001 | ||
White Female | 7.9% | 0.076 (0.059, 0.093) | < 0.001 | ||
White Male | 19.6% | 0.179 (0.161, 0.196) | < 0.001 | ||
Age, category | |||||
18–64 | Reference | Reference | |||
65–80 | -7.3% | -0.075 (-0.089, -0.062) | < 0.001 | ||
> 80 | -11.4% | -0.122 (-0.137, -0.106) | < 0.001 | ||
Body mass index, category | |||||
Healthy weight | Reference | Reference | |||
Underweight | -12.6% | -0.135 (-0.163, -0.106) | < 0.001 | ||
Overweight | 5.1% | 0.050 (0.035, 0.065) | < 0.001 | ||
Obesity | 2.6% | 0.026 (0.011, 0.040) | < 0.001 | ||
Medical History | |||||
Charlson Comorbidity Index | |||||
≥ 5 | Reference | Reference | |||
0 | 9.5% | 0.091 (0.068, 0.114) | < 0.001 | ||
1–2 | 1.8% | 0.018 (-0.006, 0.042) | 0.147 | ||
3–4 | 2.0% | 0.020 (-0.006, 0.046) | 0.137 | ||
Missing | 5.5% | 0.053 (0.025, 0.081) | < 0.001 | ||
Hospital Course | |||||
Emergency Severity Index | 3.9% | 0.038 (0.028, 0.048) | < 0.001 | ||
Use of Intravenous Vesicant | |||||
No | Reference | Reference | |||
Yes | -0.6% | -0.006 (-0.019, 0.007) | 0.358 | ||
PIVC Characteristics | |||||
Gauge | |||||
18 | Reference | Reference | |||
20 | 1.1% | 0.011 (-0.004, 0.026) | 0.152 | ||
22 | -18.8% | -0.208 (-0.237, -0.179) | < 0.001 | ||
24 | -31.2% | -0.374 (-0.488, -0.260) | < 0.001 | ||
Insertion Method | |||||
Traditional | Reference | Reference | |||
Ultrasound Guided | -18.9% | -0.209 (-0.237, -0.182) | < 0.001 | ||
Orientation | |||||
Left | Reference | Reference | |||
Right | -1.4% | -0.014 (-0.026, -0.003) | 0.014 | ||
Location | |||||
Antecubital | Reference | Reference | |||
Forearm | 6.7% | 0.065 (0.051, 0.078) | < 0.001 | ||
Hand/Wrist | -15.0% | -0.163 (-0.194, -0.132) | < 0.001 | ||
Upper Arm | -12.6% | -0.134 (-0.165, -0.104) | < 0.001 | ||
Other | -17.7% | -0.195 (-0.218, -0.171) | < 0.001 |